Ledger.Open graph →
SEC Form D · filed December 4, 2015

Prosetta Biosciences Inc

Offering
$31.1M
Sold
$31.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Thomas D. Higgins · SAN FRANCISCO, CADirectorMolly D. Coye · SAN FRANCISCO, CADirectorKarl D. Manheim · SAN FRANCISCO, CADirectorVishwanath D. Lingappa · SAN FRANCISCO, CAExec · DirectorMichael D. Farmer · SAN FRANCISCO, CAExec · DirectorYu Tsang A. Wong · Central, Hong KongExec · DirectorDavid V. Bree · Grand Cayman, Cayman IslandsExec · DirectorDina Dilorenzo · New York, NYDirectorKarl D. Manheim · SAN FRANCISCO, CADirectorCj D. Sylvester · SAN FRANCISCO, CADirectorJoseph("Mike") D. Mccune · SAN FRANCISCO, CADirectorAbel D. Weinrib · SAN FRANCISCO, CADirectorDavid D. Keys · SAN FRANCISCO, CADirectorPhil D. Satow · SAN FRANCISCO, CADirectorRoy First · Brookline, MADirectorThomas Campbell · ALEXANDRIA, VADirectorDouglas T. Lake, Jr · ALEXANDRIA, VAExec · DirectorKarim Fadel · Boston, MAExec · DirectorMolly D. Coye · SAN FRANCISCO, CADirectorCj D. Sylvester · SAN FRANCISCO, CADirectorJoseph("Mike") D. Mccune · SAN FRANCISCO, CADirectorAbel D. Weinrib · SAN FRANCISCO, CADirectorDavid D. Keys · SAN FRANCISCO, CADirectorPhil D. Satow · SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗